BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.

Katja Gutmair,

Diego Villa,

Nicholas Cunningham,

Elisabeth Silkenstedt,

Lisa M Rimsza,

Colleen A Ramsower,

David W Scott,

Alina S Gerrie,

Hanneke C Kluin-Nelemans,

Martin Dreyling,

Eva Hoster